Cardene Iv Injection, Solution
Product Images NDC 43066-016

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cardene Structural Formula (Image 01)

Chemical structure of nicardipine hydrochloride, the active ingredient in CARDENE IV injection. The diagram shows the molecular arrangement, including functional groups and bonds, with the hydrochloride salt indicated.*

FDA Label Image

Cardene Representative Container Label 1 Of 2 (Image 02)

CARDENE I.V. nicardipine hydrochloride injection, 0.2 mg/mL strength in a 200 mL single-dose container. The label details ingredients, dosage form as intravenous solution, storage instructions, warnings, and marketing by Baxter Healthcare Corporation. The product is presented as a 40 mg dose in 200 mL solution.*

FDA Label Image

Cardene Representative Container Label 2 Of 2 (Image 03)

Packaging label from the CARDENE IV injection solution by Baxter Healthcare Corporation. The label prominently features the text "*BAR CODE POSITION ONLY" above a vertical barcode number. This label is for the intravenous solution form of nicardipine hydrochloride.*

FDA Label Image

Cardene Representative Carton Label 1 Of 2 (Image 04)

Packaging label for CARDENE I.V. nicardipine hydrochloride injection, 0.2 mg/mL strength, in a 200 mL single dose container. The label shows the product name, concentration, and instructions to check infusion rate due to double concentration. The labeler is Baxter Healthcare Corporation, Deerfield, IL. The injection is in 0.83% sodium chloride solution and intended for intravenous use.*

FDA Label Image

Cardene Representative Carton Label 2 Of 2 (Image 05)

Label for CARDENE IV injection, a solution containing nicardipine hydrochloride at 0.1 mg/mL strength in a 200 mL single-dose container. The label states the drug is supplied by Baxter Healthcare Corporation, specifying its isosmotic property and sodium chloride content of 0.86%. It includes dosage form, cautionary storage instructions, and usage notes for intravenous administration.*

FDA Label Image

Cardene Representative Shipper Label 1 Of 2 (Image 06)

The image shows a label for CARDENE IV Injection, Solution containing nicardipine hydrochloride, with a barcode and the text '*BAR CODE POSITION ONLY'. The label appears to be a placement guide or sticker for labeling purposes and is from Baxter Healthcare Corporation.*

FDA Label Image

Cardene Representative Shipper Label 2 Of 2 (Image 07)

CARDENE I.V. Nicardipine Hydrochloride Injection, 0.1 mg/mL (20 mg in 200 mL) intravenous solution in 0.86% sodium chloride. Label shows this is a prescription drug by Baxter Healthcare Corporation, including storage and caution information and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.